Inogen, Inc · NASDAQ:INGN

Inogen — Q1 2024 Earnings Presentation

8 slides from Inogen's earnings presentation, May 7, 2024

  1. Slide 1: Q1 2024 Supplemental Financial Information

    May 7, 2024 Q1 2024 Supplemental Financial Information

  2. Slide 2: Use of Non-GAAP Financial Measures

    Use of Non-GAAP Financial Measures Inogen has presented certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis for the three months ended March 31, 2024, and March 31, 2023. Management believes that non-GAAP financial measures, taken in conjunction with U.S. GAAP fin

  3. Slide 3: Q1 2024 Results

    Q1 2024 Results Revenue by region and category Total by Category Q1 Revenue Year-Over-Year Change % of Total Revenue Business-to-business $16.5 million 31.3% 21.2% domestic sales Business-to-business $26.0 million 37.2% 33.4% international sales Direct-to-consumer $20.5 million (15.6)% 26.3% domesti

  4. Slide 4: Operating Expense and Net Loss

    Operating Expense and Net Loss (in thousands) Three months ended March 31, 2024 2023 Operating expense Research and development $ 6,578 $ 5,344 Sales and marketing 26,936 28,441 General and administrative 17,131 18,863 Total operating expense 50,645 52,648 Loss from operations (16,274) (21,915) Othe

  5. Slide 5: Reconciliation of GAAP to Non-GAAP: Adjusted EBITDA

    Reconciliation of GAAP to Non-GAAP Adjusted EBITDA (in thousands) Three months ended March 31, Non-GAAP EBITDA and Adjusted EBITDA 2024 2023 Net loss (GAAP) $ (14,578) $ (20,349) Non-GAAP adjustments: Interest income, net (1,403) (1,525) Provision (benefit) for income taxes (150) 196 Depreciation an

  6. Slide 6: Reconciliation of GAAP to Non-GAAP: Adjusted Net Loss

    Reconciliation of GAAP to Non-GAAP Adjusted Net Loss (in thousands) Three months ended March 31, Net Loss Diluted EPS Non-GAAP Adjusted Net Loss and Diluted EPS 2024 2023 2024 2023 Financial Results (GAAP) $ (14,578) $ (20,349) $ (0.62) $ (0.88) Non-GAAP adjustments: Amortization of intangibles 932

  7. Slide 7: Stock-Based Compensation

    Stock-Based Compensation (in thousands) Three months ended March 31, 2024 2023 Stock-based compensation expense by type of award: Restricted stock units and restricted stock awards $ 2,309 $ 3,305 Employee stock purchase plan 107 137 Total stock-based compensation expense $ 2,416 $ 3,442 Three month

  8. Slide 8: Improving lives through respiratory care

    Improving lives through respiratory care

Inogen — Q1 2024 Earnings Presentation on 6ix